Chemoinformaics analysis of 1-O-Formylrocagloic acid
| Molecular Weight | 506.507 | nRot | 8 |
| Heavy Atom Molecular Weight | 480.299 | nRig | 28 |
| Exact Molecular Weight | 506.158 | nRing | 5 |
| Solubility: LogS | -4.179 | nHRing | 1 |
| Solubility: LogP | 3.587 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 3 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 18 |
| nHA | 8 | APOL | 71.3146 |
| nHD | 2 | BPOL | 36.4994 |
| QED | 0.444 |
| Synth | 4.134 |
| Natural Product Likeliness | 1.555 |
| NR-PPAR-gamma | 0.21 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.011 |
| HIA | 0.037 |
| CACO-2 | -5.709 |
| MDCK | 0.000021 |
| BBB | 0.312 |
| PPB | 0.880198 |
| VDSS | 1.046 |
| FU | 0.0895437 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.58 |
| CYP2c19-inh | 0.324 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.746 |
| CYP2c9-sub | 0.754 |
| CYP2d6-inh | 0.044 |
| CYP2d6-sub | 0.706 |
| CYP3a4-inh | 0.762 |
| CYP3a4-sub | 0.666 |
| CL | 5.603 |
| T12 | 0.394 |
| hERG | 0.063 |
| Ames | 0.508 |
| ROA | 0.787 |
| SkinSen | 0.029 |
| Carcinogencity | 0.536 |
| EI | 0.011 |
| Respiratory | 0.866 |
| NR-Aromatase | 0.863 |
| Antiviral | Yes |
| Prediction | 0.908697 |